Jr. Ackland et al., VACCINE PROPHYLAXIS OF Q-FEVER - A FOLLOW-UP-STUDY OF THE EFFICACY OFQ-VAX (CSL) 1985-1990, Medical journal of Australia, 160(11), 1994, pp. 704-708
Objectives: To examine the efficacy of various batches of a formalin-i
nactivated whole cell Coxiella burnetii vaccine (Henzerling strain, Ph
ase 1 [Q-Vax, CSL]) in the prevention of Q fever among abattoir worker
s. Design and setting: The study was a retrospective cohort survey of
all employees at three South Australian abattoirs to determine the inc
idence of Q fever among vaccinated and unvaccinated employees during t
he period 1985 to 1990. Results: There were two cases of Q fever among
2555 vaccinated employees of the three abattoirs, compared with 55 ca
ses among 1365 unvaccinated employees. The two Q fever cases in vaccin
ated employees were within a few days of vaccination, before immunity
had developed, and represented a coincidence of natural infection and
vaccination. Protective efficacy was 100%, even with a batch of Q-Vax
containing 20 mu g/dose rather than the standard dose of 30 mu g/dose.
Conclusions: Vaccination was effective for at least five years, altho
ugh it was uncertain whether this was due to the vaccine per se or to
a combination of vaccine immunity reinforced by periodic natural expos
ure.